These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 692251)

  • 1. Further data on the effect of ethionamide and prothionamide in experimental leprosy.
    Pattyn SR
    Lepr Rev; 1978 Sep; 49(3):199-202. PubMed ID: 692251
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review.
    Colston MJ; Ellard GA; Gammon PT
    Lepr Rev; 1978 Jun; 49(2):115-26. PubMed ID: 661479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacteriostatic activity of blood in single and combined use of ethionamide or prothionamide].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1975; (5):70-3. PubMed ID: 1144350
    [No Abstract]   [Full Text] [Related]  

  • 4. Prothionamide and prothionamide-S-oxide in experimental leprosy.
    Matsuo Y; Tatsukawa H; Murray JF; Peters JH
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):302-6. PubMed ID: 6459296
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
    Gupta DK; Mital OP; Agarwal MC; Kansal HM; Nath S
    J Indian Med Assoc; 1977 Jan; 68(2):25-9. PubMed ID: 326974
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of leprosy with rifampicin and isoprodian (L73A).
    Terencio de las Aguas J
    Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin and isoprodian in combination in the treatment of leprosy.
    Depasquale G
    Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
    Freerksen E
    Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S; Leguizamón OR; Alvarenga AE
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary experience with rifampicin and isoprodian (L73A)--combination in lepromatous leprosy.
    Hamzah M; Kosasih A
    Lepr Rev; 1975 Jun; 46(2 Suppl):181-7. PubMed ID: 1100959
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT; Guinto RS; Cellona RV; Abalos RM; Dela Cruz EC; Gelber RH
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
    Rohde R
    Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
    Aschhoff M
    Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethionamide, prothionamide and thiacetazone self-administration. Studies of patient compliance using isoniazid-marked formulations.
    Stanley JN; Pearson JM; Ellard GA
    Lepr Rev; 1986 Mar; 57(1):9-18. PubMed ID: 2422517
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Probl Tuberk; 1973; 51(10):37-40. PubMed ID: 4784035
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
    Colin M; de Montaigne E
    Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New drugs in the treatment of leprosy].
    De Las Aguas JT
    Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.